# Phase 2: Regulated Use Roadmap

This document outlines the hardening steps toward HIPAA/21 CFR Part 11/GLP/GCP‑aligned use.

## Audit Logging and Traceability
- Append‑only audit log for authentication, access, changes, and outputs
- Immutable storage (e.g., object store with WORM, tamper‑evident hashing)
- Correlate with request IDs; capture user, time, action, inputs/outputs metadata

## E‑Signatures and Approvals
- Part 11 compliant e‑sign flows for critical actions (approve/release)
- Dual‑control policies configurable per workflow

## Provenance and Evidence
- Record model provider, version, parameters, prompts, and outputs
- Persist citations, disclaimers, verification results (Overwatch) with artifacts
- Export evidence packages for validation and audits

## Validation and Qualification
- Validation plan, protocols (IQ/OQ/PQ), and executed evidence
- Change control, configuration management, and release notes process

## Integrations (LIMS/ELN/EHR)
- Adapters for common systems (REST/HL7/FHIR as applicable)
- Data mapping with schema validation and provenance tags

## Security & Privacy Enhancements
- Full RBAC with least privilege and scoped tokens
- Secrets via ESO/Vault with rotation SLAs
- PHI/PII handling policies, data retention, and DLP scanning

## Operational Controls
- SLOs with paging policies; error budgets and change freezes
- DR: regular restore drills and automated runbooks

## Deliverables
- Policies and SOPs; training and access certification
- Validation summary report; vendor and third‑party assurances
